[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Berryman et al., 2013 - Google Patents

The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations

Berryman et al., 2013

Document ID
12757540896304372860
Author
Berryman D
Glad C
List E
Johannsson G
Publication year
Publication venue
Nature Reviews Endocrinology

External Links

Snippet

Obesity has become one of the most common medical problems in developed countries, and this disorder is associated with high incidences of hypertension, dyslipidaemia, cardiovascular disease, type 2 diabetes mellitus and specific cancers. Growth hormone (GH) …
Continue reading at www.nature.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Similar Documents

Publication Publication Date Title
Berryman et al. The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations
Kopchick et al. The effects of growth hormone on adipose tissue: old observations, new mechanisms
Huang et al. Insulin and growth hormone balance: implications for obesity
Stanford et al. Muscle-adipose tissue cross talk
Delhanty et al. Ghrelin and glucose homeostasis
Bauche et al. Adiponectin downregulates its own production and the expression of its AdipoR2 receptor in transgenic mice
Lichanska et al. How growth hormone controls growth, obesity and sexual dimorphism
Lin et al. Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissues
Velloso Regulation of muscle mass by growth hormone and IGF‐I
Tschöp et al. GH-releasing peptide-2 increases fat mass in mice lacking NPY: indication for a crucial mediating role of hypothalamic agouti-related protein
Smith et al. Developments in ghrelin biology and potential clinical relevance
Berryman et al. Growth hormone and adipose tissue: beyond the adipocyte
Kajimura et al. A new era in brown adipose tissue biology: molecular control of brown fat development and energy homeostasis
Ferron et al. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice
Delhanty et al. Ghrelin and bone
Liu et al. Hypoglycemia and impaired hepatic glucose production in mice with a deletion of the C/EBPβ gene
Chaves et al. The metabolic effects of growth hormone in adipose tissue
Botelho et al. Neuropeptide Y: an anti-aging player?
Peier et al. Effects of peripherally administered neuromedin U on energy and glucose homeostasis
Brandt et al. Over-expression of Follistatin-like 3 attenuates fat accumulation and improves insulin sensitivity in mice
Harrison et al. Photoperiod influences the central effects of ghrelin on food intake, GH and LH secretion in sheep
Cervone et al. Regulation of adipose tissue and skeletal muscle substrate metabolism by the stomach-derived hormone, ghrelin
Duran-Ortiz et al. Disruption of the GH receptor gene in adult mice and in insulin sensitive tissues
Young et al. Musculoskeletal effects of altered GH action
Narimatsu et al. Hypothalamic overexpression of neurosecretory protein GL leads to obesity in male C57BL/6J mice